BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 22087551)

  • 1. The impact and management of nonmotor symptoms of Parkinson's disease.
    Lyons KE; Pahwa R
    Am J Manag Care; 2011 Oct; 17 Suppl 12():S308-14. PubMed ID: 22087551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.
    Seppi K; Weintraub D; Coelho M; Perez-Lloret S; Fox SH; Katzenschlager R; Hametner EM; Poewe W; Rascol O; Goetz CG; Sampaio C
    Mov Disord; 2011 Oct; 26 Suppl 3(0 3):S42-80. PubMed ID: 22021174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity.
    Taylor TN; Caudle WM; Shepherd KR; Noorian A; Jackson CR; Iuvone PM; Weinshenker D; Greene JG; Miller GW
    J Neurosci; 2009 Jun; 29(25):8103-13. PubMed ID: 19553450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autonomic Dysfunction in Parkinson's Disease.
    Pfeiffer RF
    Neurotherapeutics; 2020 Oct; 17(4):1464-1479. PubMed ID: 32789741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.
    Seppi K; Ray Chaudhuri K; Coelho M; Fox SH; Katzenschlager R; Perez Lloret S; Weintraub D; Sampaio C;
    Mov Disord; 2019 Feb; 34(2):180-198. PubMed ID: 30653247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care.
    Taylor J; Anderson WS; Brandt J; Mari Z; Pontone GM
    Am J Geriatr Psychiatry; 2016 Dec; 24(12):1171-1180. PubMed ID: 27746069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between falls and nonmotor symptoms in patients with Parkinson's disease.
    Li Z; Jiang X; Yang M; Pan Y
    J Clin Neurosci; 2023 Dec; 118():143-146. PubMed ID: 37939511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition and management of neuropsychiatric complications in Parkinson's disease.
    Ferreri F; Agbokou C; Gauthier S
    CMAJ; 2006 Dec; 175(12):1545-52. PubMed ID: 17146092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.
    Connolly B; Fox SH
    Neurotherapeutics; 2014 Jan; 11(1):78-91. PubMed ID: 24288035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.
    Palma JA; Kaufmann H
    Mov Disord; 2018 Mar; 33(3):372-390. PubMed ID: 29508455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review.
    Mitchell SD; Sidiropoulos C
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33808714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.
    Reynolds GO; Otto MW; Ellis TD; Cronin-Golomb A
    Mov Disord; 2016 Jan; 31(1):23-38. PubMed ID: 26715466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentations of nonmotor symptoms by sex and onset age in people with Parkinson's disease.
    Lee J; Sohn YH; Chung SJ; Kim E; Kim Y
    Int J Nurs Pract; 2024 Apr; 30(2):e13177. PubMed ID: 37394896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and management of the non-motor features of Parkinson's disease.
    Wishart S; Macphee GJ
    Ther Adv Chronic Dis; 2011 Mar; 2(2):69-85. PubMed ID: 23251743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease: the quintessential neuropsychiatric disorder.
    Weintraub D; Burn DJ
    Mov Disord; 2011 May; 26(6):1022-31. PubMed ID: 21626547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected.
    Todorova A; Jenner P; Ray Chaudhuri K
    Pract Neurol; 2014 Oct; 14(5):310-22. PubMed ID: 24699931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship Between Autonomic Dysfunction and Mood Symptoms in De Novo Parkinson's Disease Patients Over Time.
    Ratajska AM; Etheridge CB; Lopez FV; Kenney LE; Rodriguez K; Schade RN; Gertler J; Bowers D
    J Geriatr Psychiatry Neurol; 2024 May; 37(3):242-252. PubMed ID: 37831611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and Rehabilitation.
    Magrinelli F; Picelli A; Tocco P; Federico A; Roncari L; Smania N; Zanette G; Tamburin S
    Parkinsons Dis; 2016; 2016():9832839. PubMed ID: 27366343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmotor symptoms in a malaysian Parkinson's disease population.
    Azmin S; Khairul Anuar AM; Tan HJ; Nafisah WY; Raymond AA; Hanita O; Shah SA; Norlinah MI
    Parkinsons Dis; 2014; 2014():472157. PubMed ID: 24800102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced Parkinson's or "complex phase" Parkinson's disease? Re-evaluation is needed.
    Titova N; Martinez-Martin P; Katunina E; Chaudhuri KR
    J Neural Transm (Vienna); 2017 Dec; 124(12):1529-1537. PubMed ID: 29116411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.